CinCor Pharma Competitors and Similar CompaniesClear all
CinCor Pharma's competitors and similar companies include Immatics and Pharming Group.
 CinCor Pharma CinCor Pharma is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic, and kidney diseases. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | |
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 1988 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Leiden, NL HQ Leiden, NL |
Employees | Employees 5 | Employees 29723% increase | Employees 404 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 590.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $376.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit $341m (FY, 2025) |
Net income | Net income ($50.4m) (FY, 2021) | Net income (€196.4m) (FY, 2025) | Net income $2.5m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 193m | Total funding raised $ 267.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyPharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View company